14,251 Shares in U.S. Physical Therapy, Inc. $USPH Acquired by Integrated Quantitative Investments LLC

Integrated Quantitative Investments LLC acquired a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH) during the second quarter, Holdings Channel.com reports. The institutional investor acquired 14,251 shares of the company’s stock, valued at approximately $1,114,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of U.S. Physical Therapy by 952.4% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company’s stock worth $32,000 after acquiring an additional 400 shares during the last quarter. Parallel Advisors LLC boosted its holdings in U.S. Physical Therapy by 90.6% in the second quarter. Parallel Advisors LLC now owns 448 shares of the company’s stock valued at $35,000 after acquiring an additional 213 shares during the last quarter. Cullen Frost Bankers Inc. increased its position in U.S. Physical Therapy by 171.8% in the second quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock worth $35,000 after purchasing an additional 280 shares during the period. Assetmark Inc. raised its holdings in U.S. Physical Therapy by 35.7% during the 2nd quarter. Assetmark Inc. now owns 570 shares of the company’s stock worth $45,000 after purchasing an additional 150 shares during the last quarter. Finally, Huntington National Bank raised its holdings in U.S. Physical Therapy by 71.9% during the 2nd quarter. Huntington National Bank now owns 667 shares of the company’s stock worth $52,000 after purchasing an additional 279 shares during the last quarter.

U.S. Physical Therapy Stock Performance

USPH stock opened at $71.58 on Friday. The business’s 50-day moving average price is $84.25 and its two-hundred day moving average price is $80.15. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The firm has a market cap of $1.09 billion, a PE ratio of 31.26, a P/E/G ratio of 4.41 and a beta of 1.47. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The company had revenue of $140.66 million for the quarter. As a group, research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 12th. Shareholders of record on Monday, November 17th will be paid a $0.45 dividend. The ex-dividend date of this dividend is Monday, November 17th. This represents a $1.80 dividend on an annualized basis and a yield of 2.5%. U.S. Physical Therapy’s payout ratio is presently 75.63%.

Wall Street Analysts Forecast Growth

USPH has been the topic of several recent research reports. JPMorgan Chase & Co. began coverage on shares of U.S. Physical Therapy in a research note on Thursday, September 18th. They issued an “overweight” rating and a $110.00 target price on the stock. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, October 8th. Zacks Research upgraded U.S. Physical Therapy to a “hold” rating in a report on Friday, August 8th. Wall Street Zen lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Sunday, September 21st. Finally, Barrington Research restated an “outperform” rating and set a $103.00 target price on shares of U.S. Physical Therapy in a report on Friday, October 24th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

Insider Transactions at U.S. Physical Therapy

In other news, COO Eric Joseph Williams sold 1,000 shares of the stock in a transaction on Friday, September 5th. The shares were sold at an average price of $85.25, for a total transaction of $85,250.00. Following the completion of the sale, the chief operating officer owned 25,331 shares of the company’s stock, valued at $2,159,467.75. This represents a 3.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Christopher J. Reading sold 2,000 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $83.53, for a total transaction of $167,060.00. Following the sale, the chief executive officer owned 114,088 shares in the company, valued at approximately $9,529,770.64. The trade was a 1.72% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 5,061 shares of company stock valued at $426,273. 2.00% of the stock is currently owned by insiders.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.